Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$751M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$692M |
| 3 |
Palantir
PLTR
|
+$434M |
| 4 |
Union Pacific
UNP
|
+$377M |
| 5 |
AbbVie
ABBV
|
+$367M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.74B |
| 2 |
Meta Platforms (Facebook)
META
|
+$602M |
| 3 |
Bank of America
BAC
|
+$600M |
| 4 |
Wells Fargo
WFC
|
+$568M |
| 5 |
Broadcom
AVGO
|
+$538M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.73% |
| 2 | Financials | 7.42% |
| 3 | Healthcare | 6.65% |
| 4 | Industrials | 6.3% |
| 5 | Consumer Discretionary | 5.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Celldex Therapeutics
CLDX
$2.94B
| $9.71M | ﹤0.01% |
477,227
+77,295
| +19% | +$1.5M |
|
2202
PUT
Alcon
ALC
$34B
| $9.71M | ﹤0.01% |
110,000
-38,500
| -26% | -$3.45M |
|
2203
Williams-Sonoma
WSM
$27.5B
| $9.7M | ﹤0.01% |
59,397
-498,477
| -89% | -$78.3M |
|
2204
PUT
Bilibili
BILI
$7.75B
| $9.7M | ﹤0.01% |
452,300
-525,100
| -54% | -$9.66M |
|
|
ECHO
2205
CALL
EchoStar
ECHO
$24.3B
| $9.7M | ﹤0.01% |
+350,000
| New | +$7.69M |
|
2206
Amylyx Pharmaceuticals
AMLX
$2.19B
| $9.69M | ﹤0.01% |
1,512,058
-1,569,795
| -51% | -$7.64M |
|
2207
CALL
Consolidated Edison
ED
$41.4B
| $9.68M | ﹤0.01% |
96,500
+77,900
| +419% | +$8.25M |
|
2208
Simulations Plus
SLP
$371M
| $9.68M | ﹤0.01% |
554,880
+504,901
| +1,010% | +$14.2M |
|
|
TACH
2209
Titan Acquisition Corp
TACH
$360M
| $9.68M | ﹤0.01% |
+960,000
| New | +$9.65M |
|
2210
Koppers
KOP
$946M
| $9.67M | ﹤0.01% |
300,825
+60,019
| +25% | +$1.72M |
|
2211
Napco Security Technologies
NSSC
$1.3B
| $9.66M | ﹤0.01% |
325,414
-444,375
| -58% | -$11.4M |
|
2212
Marcus Corp
MCS
$767M
| $9.66M | ﹤0.01% |
572,717
+180,083
| +46% | +$3.04M |
|
2213
Unity
U
$14B
| $9.65M | ﹤0.01% |
398,806
+147,909
| +59% | +$3.25M |
|
2214
CALL
Chewy
CHWY
$9.54B
| $9.63M | ﹤0.01% |
225,900
-27,700
| -11% | -$1.1M |
|
2215
F&G Annuities & Life
FG
$3.91B
| $9.63M | ﹤0.01% |
301,046
+83,740
| +39% | +$2.78M |
|
2216
PUT
Martin Marietta Materials
MLM
$34.2B
| $9.61M | ﹤0.01% |
17,500
+16,400
| +1,491% | +$8.67M |
|
2217
Westamerica Bancorp
WABC
$1.39B
| $9.61M | ﹤0.01% |
+198,313
| New | +$9.5M |
|
2218
World Kinect Corp
WKC
$2.06B
| $9.59M | ﹤0.01% |
338,312
-187,385
| -36% | -$4.97M |
|
|
ABVX
2219
Abivax
ABVX
$10.4B
| $9.58M | ﹤0.01% |
1,251,765
+264,351
| +27% | +$1.72M |
|
2220
Equinor
EQNR
$97.3B
| $9.56M | ﹤0.01% |
380,152
+229,903
| +153% | +$5.56M |
|
2221
Oportun Financial
OPRT
$262M
| $9.54M | ﹤0.01% |
1,333,050
-603,747
| -31% | -$3.62M |
|
2222
PUT
Lockheed Martin
LMT
$131B
| $9.54M | ﹤0.01% |
20,600
-17,100
| -45% | -$8M |
|
2223
RH
RH
$3.33B
| $9.54M | ﹤0.01% |
50,456
+43,516
| +627% | +$8.08M |
|
2224
Paychex
PAYX
$43.4B
| $9.53M | ﹤0.01% |
65,528
-12,336
| -16% | -$1.86M |
|
|
BBOT
2225
BridgeBio Oncology
BBOT
$660M
| $9.53M | ﹤0.01% |
897,251
-199,131
| -18% | -$2.15M |
|
Similar funds
Millennium Management's Q2 2025 Portfolio in Review
As of Q2 2025, Millennium Management held 6,516 positions worth $207B, up 10% from $188B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Millennium Management's Q2 2025 filing shows 738 new, 2,295 increased, 2,418 reduced and 712 closed positions. Its largest new stake was Bank of America Series L: 164,000 shares worth $197K. The largest sale was iShares Core S&P 500 ETF, an estimated $1.74B.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 7.8% a quarter earlier, followed by Financials and Healthcare.
- Millennium Management's largest Q2 2025 buy was Bank of America Series L: 164,000 shares worth $197K.
- Millennium Management added most to Applovin in Q2 2025, an estimated $751M increase.
- Millennium Management's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.74B.
- Millennium Management fully exited Discover Financial Services in Q2 2025, selling an estimated $282M.
- Millennium Management's ten largest holdings make up 16% of its $207B portfolio in Q2 2025.
- Millennium Management opened 738 new positions and closed 712 in Q2 2025.
- Millennium Management's portfolio value rose 10% quarter-over-quarter to $207B.
Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.